Sequence Bio

Sequence Bio

Sequence Bio is a biotechnology company combining genomic, multi-omic population data and longitudinal health records from the unique founder population of Newfoundland and Labrador, Canada to find drug targets.

All edits

Edits on 29 July, 2020
Jed Christiansen
Jed Christiansen edited on 29 July, 2020 5:59 am
Edits made to:
Infobox (+1 properties)
Infobox
Jed Christiansen
Jed Christiansen edited on 29 July, 2020 5:58 am
Edits made to:
Infobox (+1/--1 properties)
Infobox
Edits on 18 August, 2019
Jed Christiansen
Jed Christiansen edited on 18 August, 2019 10:03 pm
Edits made to:
Infobox (+2 properties)
Article
Article

Biotechnology company combining genomic, multi-omic population data and longitudinal health records from the unique founder population of Newfoundland and Labrador, Canada to find drug targets. Sequence Bio makes use of Newfoundland and Labrador’s founder population and unique history as a cohort to explore to disease preventions and treatments. This population has a high rate of complex and inherited diseases which provides an opportunity to find underlying differences that affect disease and health. Findings are expected to improve the lives of people in Newfoundland and Labrador (NL) and around the world. One of the goals is the share research findings and integrate precision into their local healthcare system.

Infobox
Location
Company status
Active
Accelerator
Accelerator Batch
Edits on 16 August, 2019
Will Suter
Will Suter approved a suggestion from Golden's AI on 16 August, 2019 6:27 pm
Edits made to:
Article (+3/-3 characters)
Article

Sequence Bio is leading the NL Genome Project, a large-scale genomics research study that uses saliva samples for researching DNADNA combined with medical information in 2500 volunteers. Volunteers are enrolled at select doctor’s offices in the province.

Will Suter
Will Suter approved a suggestion from Golden's AI on 16 August, 2019 6:27 pm
Edits made to:
Article (+13/-13 characters)
Article

BiotechnologyBiotechnology company combining genomic, multi-omic population data and longitudinal health records from the unique founder population of Newfoundland and Labrador, Canada to find drug targets. Sequence Bio makes use of Newfoundland and Labrador’s founder population and unique history as a cohort to explore to disease preventions and treatments. This population has a high rate of complex and inherited diseases which provides an opportunity to find underlying differences that affect disease and health. Findings are expected to improve the lives of people in Newfoundland and Labrador (NL) and around the world. One of the goals is the share research findings and integrate precision into their local healthcare system.

Will Suter
Will Suter approved a suggestion from Golden's AI on 16 August, 2019 6:21 pm
Edits made to:
Article (+20/-20 characters)
Article

CEO Chris Gardner was appointed to the federal Health/Bio-sciences Economic Strategy Table by the Minister of Innovation, Science and Economic DevelopmentEconomic Development. CSO Michael S. Phillips previously held roles at Genomics Medicine Ireland and Merck. The company won the Community Impact and Business Excellence awards at the St. John’s Board of Trade Awards. Sequence Bio worked with Senator Jim Cowan to support passage of Bill S201 that ensures all Canadians are protected from genetic discrimination.

Will Suter
Will Suter approved a suggestion from Golden's AI on 16 August, 2019 6:19 pm
Edits made to:
Article (+6/-6 characters)
Article

Biotechnology company combining genomic, multi-omic population data and longitudinal health records from the unique founder population of Newfoundland and Labrador, CanadaCanada to find drug targets. Sequence Bio makes use of Newfoundland and Labrador’s founder population and unique history as a cohort to explore to disease preventions and treatments. This population has a high rate of complex and inherited diseases which provides an opportunity to find underlying differences that affect disease and health. Findings are expected to improve the lives of people in Newfoundland and Labrador (NL) and around the world. One of the goals is the share research findings and integrate precision into their local healthcare system.

Edits on 16 August, 2019
Meredith Hanel
Meredith Hanel edited on 16 August, 2019 12:09 pm
Edits made to:
Infobox (+3 properties)
Timeline (+1 events) (+41 characters)
Description (+212/-37 characters)
Article (+1474 characters)
Documentaries, videos and podcasts (+1 rows) (+3 cells) (+109 characters)
Topic thumbnail

Sequence Bio

Drug research and development company

Sequence Bio is a biotechnology company combining genomic, multi-omic population data and longitudinal health records from the unique founder population of Newfoundland and Labrador, Canada to find drug targets.

Article

Biotechnology company combining genomic, multi-omic population data and longitudinal health records from the unique founder population of Newfoundland and Labrador, Canada to find drug targets. Sequence Bio makes use of Newfoundland and Labrador’s founder population and unique history as a cohort to explore to disease preventions and treatments. This population has a high rate of complex and inherited diseases which provides an opportunity to find underlying differences that affect disease and health. Findings are expected to improve the lives of people in Newfoundland and Labrador (NL) and around the world. One of the goals is the share research findings and integrate precision into their local healthcare system.

CEO Chris Gardner was appointed to the federal Health/Bio-sciences Economic Strategy Table by the Minister of Innovation, Science and Economic Development. CSO Michael S. Phillips previously held roles at Genomics Medicine Ireland and Merck. The company won the Community Impact and Business Excellence awards at the St. John’s Board of Trade Awards. Sequence Bio worked with Senator Jim Cowan to support passage of Bill S201 that ensures all Canadians are protected from genetic discrimination.

Sequence Bio is leading the NL Genome Project, a large-scale genomics research study that uses saliva samples for researching DNA combined with medical information in 2500 volunteers. Volunteers are enrolled at select doctor’s offices in the province.

Documentaries, videos and podcasts

Title
Date
Link

Sequence Bio launches N.L. Genome Project

July 24, 2019

Infobox
Date incorporated
2013
Timeline

July 24, 2019

Sequence Bio launches N.L. Genome Project

Edits on 29 May, 2019
Golden AI
Golden AI edited on 29 May, 2019 2:33 pm
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 21 January, 2019
Golden AI"Changed markets to industries"
Golden AI edited on 21 January, 2019 10:11 pm
Edits made to:
Infobox (+3/-3 properties)
Infobox
Edits on 10 January, 2019
Golden AI
Golden AI edited on 10 January, 2019 12:00 am
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 12 December, 2018
Golden AI"Import data"
Golden AI edited on 12 December, 2018 1:11 am
Edits made to:
Infobox (+5 properties)
People (+13 rows) (+26 cells) (+326 characters)
Categories (+1 topics)
People

Name
Role
Related Golden topics

Chris McDonald

Employee

Dan Brake

Employee

David Phillips, CPA, CA

Employee

James Hardiman

Board member

Jeremy Grushcow, Ph.D., J.D.

Employee

John Phillips

Advisor

Mark Dobbin

Board member

Matthew Stenback

Employee

Michael Phillips

Employee

Neala Quigley

Employee

Pelorus Venture Capital Limited

Investor

Sophie Harrington

Employee

Tyler Wish

Employee

Infobox
Categories
Edits on 19 July, 2018
Golden AI"Update locations in infobox"
Golden AI edited on 19 July, 2018 8:48 pm
Infobox
Edits on 16 July, 2018
Golden AI"Update markets in infobox"
Golden AI edited on 16 July, 2018 11:37 pm
Infobox
Edits on 29 June, 2018
Golden AI"Update infobox"
Golden AI edited on 29 June, 2018 5:39 pm
Infobox
Edits on 11 June, 2018
Golden AI"Updating description"
Golden AI edited on 11 June, 2018 7:18 pm
Edits made to:
Description (+37/-21 characters)
Topic thumbnail

Sequence Bio

Biotechnology company

Drug research and development company

Edits on 30 May, 2018
Golden AI"Initial topic creation"
Golden AI created this topic on 30 May, 2018 10:43 pm
Edits made to:
Description (+21 characters)
People (+1 rows) (+2 cells) (+22 characters)
Categories (+1 topics)
Topic thumbnail

 Sequence Bio

Biotechnology company

People

Name
Role
Related Golden topics

Chris C Gardner

Founder

Categories
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.